TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CING

Cingulate Inc

Healthcare · Biotechnology

4.90$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

Cingulate Inc (CING) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CING
Line item Q2 23 Q3 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.0 0.0 -3,850 0.0 0.0 12,982 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 -0.4 0.1 – –
-0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.2 -0.1 -0.1 0.4 -0.1 – –
4.5 3.9 1.8 1.9 1.4 4.3 2.2 2.7 2.8 2.0 2.2 1.5 8.5
1.9 1.8 1.1 1.3 1.9 1.9 1.5 1.9 3.1 3.6 5.7 3.9 16
6.4 5.7 2.9 3.2 3.3 6.2 3.7 4.6 6.0 5.6 7.9 5.4 25
-6.4 -5.7 -2.9 -3.2 -3.3 -6.2 -3.7 -4.6 -6.0 -5.6 -7.9 -5.4 -25
254 0.2 408 0.0 50 0.1 97 139 573 1.4 – 0.1 –
-6.6 -6.0 -3.0 -3.2 -4.1 -6.1 -3.9 -4.8 -7.3 -6.3 -9.3 -5.9 -29
6,109 -0.2 -0.2 – – – – – – – – – –
-6.6 -6.0 -3.0 -3.2 -4.1 -6.1 -3.9 -4.8 -7.3 -6.3 -9.3 -5.9 -29
-6.2 -5.6 -2.8 -3.0 -3.1 -6.0 -3.5 -4.5 -5.9 -5.5 -7.8 214 194

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?